Publications and reports
Below is a list of publications that use data held by the Cancer Institute NSW.
This includes:
- NSW Cancer Registry
- NSW Clinical Cancer Registry (2008–2012)
- BreastScreen NSW
- NSW Pap Test Register
- Cancer Institute Tobacco Tracking Survey
Published date 13 May 2019
Classifying people at high risk of melanoma based on number of naevi should take into account their country of residence, type of counts, body site and more.
Published date 10 May 2019
Low self-rated health may be a flag for undiagnosed cancer, and an investigation of its clinical utility in primary care appears warranted.
Published date 08 May 2019
Between 2018 and 2040, the number of patients requiring first-course chemotherapy annually will increase from 9·8 million to 15·0 million.
Published date 06 May 2019
177 Lu-DOTATATE is a promising treatment for advanced neuroendocrine tumours.
Published date 20 April 2019
The consistent association with educational attainment suggests low health literacy may play a role in a cancer of unknown primary diagnosis.
Published date 18 April 2019
Regular use of aspirin and COX-2 inhibitors might reduce breast cancer risk for women at familial or genetic risk.
Published date 08 April 2019
Incidence and mortality associated with liver cancer have increased substantially in the past three decades, in contrast to the improved outcomes observed for many other cancers.
Published date 03 April 2019
Source:
AIDS. 2019 Jul 1;33(8):1361-1368
People living with HIV in Australia are at a markedly higher risk of anal cancer, and the incidence of anal cancer is increasing in this population.
Published date 29 March 2019
Differences in cancer incidence by age at diagnosis between Aboriginal and non-Aboriginal people for
Age-specific incidence rate ratios (IRRs) were lower/similar for breast and bowel cancers in younger and higher in older Aboriginal than non-Aboriginal people. All age-specific cervical cancer IRRs were higher for Aboriginal compared with non-Aboriginal people.
Published date 29 March 2019
Excess body fatness, a trait that is of high and increasing prevalence globally, is responsible for a large proportion of the endometrial cancer burden, indicating the need for effective strategies to reduce adiposity.
